← Metformin × all-cause mortality

SynthesisClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2020

The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.

Y Shuai et al.PubMed ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation · may be no link

No clear link with deaths

−18%−40% to +11%

Bigger than 6 in 10 for all-cause mortality

As reported

HR 0.817, 95% CI 0.60–1.11 · the paper's word: All-cause mortality

Correlation · may be no link

No clear link with deaths

−18%−39% to +11%

Bigger than 5 in 10 for all-cause mortality

As reported

HR 0.824, 95% CI 0.61–1.11 · the paper's word: All-cause mortality

Two numbers in the abstract

the abstract, start to end

… with increased overall survival rate (HR 0.817; 95% CI 0.600-1.113) and cancer-specific survival rate (HR 0.824; 95% CI 0.614-1.106) of T2DM …

← favours treatmentfavours comparator →
could be chance
All-cause mortality
HR 0.8170.60–1.11
All-cause mortality
HR 0.8240.61–1.11
MetforminAll-cause mortality
1 / 3

29 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32060719